MedPath

A Phase 2 Dose Response Study of LY2484595 in Japanese Subjects

Phase 2
Recruiting
Conditions
Dyslipidemias
Registration Number
JPRN-jRCT2080221488
Lead Sponsor
Eli Lilly Japan K.K.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Subjects are man or women >20 years of age, who have low HDL-C or high LDL-C without clinical manifestation of coronary heart disease.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath